Anne Philippi

Anne Philippi

Auto-generated profile, based on publicly available information

Anne Philippi

INSERM UMRS 958, Faculté de Médecine Paris Diderot, Université Paris Diderot-Paris 7, Université Sorbonne Paris Cité, Paris, France

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SMSrinivasan Madabushi
Srinivasan Madabushi
HYHui Yao
Hui Yao
MMMike Marsh
Mike Marsh
DKDavid M Kristensen
David M Kristensen
APAnne Philippi
Anne Philippi
OLOlivier Lichtarge
Olivier Lichtarge

10 June 2015 in Brain
Verified
Journal Article
Open access
PDF file
EVEdgard Verdura
Edgard Verdura
DHDominique Hervé
Dominique Hervé
ESEva Scharrer
Eva Scharrer
MAMaria del Mar Amador
Maria del Mar Amador
LGLucie Guyant-Maréchal
Lucie Guyant-Maréchal
ETElisabeth Tournier-Lasserve
Elisabeth Tournier-Lasserve
Cerebral small vessel disease represents a heterogeneous group of disorders leading to stroke and cognitive impairment. While most small vessel diseases appear sporadic and related to age and hypertension, several early-onset monogenic forms have also been reported. However, only a minority of patients with familial small vessel disease carry mutations in one of known small vessel disease genes. We used whole exome sequencing to identify candidate genes in an autosomal dominant small vessel disease family in which known small vessel disease genes had been excluded, and subsequently screened all candidate genes in 201 unrelated probands with a familial small vessel disease of unknown aetiology, using high throughput multiplex polymerase chain reaction and next generation sequencing. A heterozygous HTRA1 variant (R166L), absent from 1000 Genomes and Exome Variant Server databases and predicted to be deleterious by in silico tools, was identified in all affected members of the index family. Ten probands of 201 additional unrelated and affected probands (4.97%) harboured a heterozygous HTRA1 mutation predicted to be damaging. There was a highly significant difference in the number of likely deleterious variants in cases compared to controls (P = 4.2 × 10−6; odds ratio = 15.4; 95% confidence interval = 4.9–45.5), strongly suggesting causality. Seven of these variants were located within or close to the HTRA1 protease domain, three were in the N-terminal domain of unknown function and one in the C-terminal PDZ domain. In vitro activity analysis of HTRA1 mutants demonstrated a loss of function effect. Clinical features of this autosomal dominant small vessel disease differ from those of CARASIL and CADASIL by a later age of onset and the absence of the typical extraneurological features of CARASIL. They are similar to those of sporadic small vessel disease, except for their familial nature. Our data demonstrate that heterozygous HTRA1 mutations are an important cause of familial small vessel disease, and that screening of HTRA1 should be considered in all patients with a hereditary small vessel disease of unknown aetiology.

1 February 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SMSrinivasan Madabushi
Srinivasan Madabushi
AGAlecia K. Gross
Alecia K. Gross
APAnne Philippi
Anne Philippi
EMElaine C. Meng
Elaine C. Meng
TWTheodore G Wensel
Theodore G Wensel
OLOlivier Lichtarge
Olivier Lichtarge
G protein-coupled receptor (GPCR) activation mediated by ligand-induced structural reorganization of its helices is poorly understood. To determine the universal elements of this conformational switch, we used evolutionary tracing (ET) to identify residue positions commonly important in diverse GPCRs. When mapped onto the rhodopsin structure, these trace residues cluster into a network of contacts from the retinal binding site to the G protein-coupling loops. Their roles in a generic transduction mechanism were verified by 211 of 239 published mutations that caused functional defects. When grouped according to the nature of the defects, these residues sub-divided into three striking sub-clusters: a trigger region, where mutations mostly affect ligand binding, a coupling region near the cytoplasmic interface to the G protein, where mutations affect G protein activation, and a linking core in between where mutations cause constitutive activity and other defects. Differential ET analysis of the opsin family revealed an additional set of opsin-specific residues, several of which form part of the retinal binding pocket, and are known to cause functional defects upon mutation. To test the predictive power of ET, we introduced novel mutations in bovine rhodopsin at a globally important position, Leu-79, and at an opsin-specific position, Trp-175. Both were functionally critical, causing constitutive G protein activation of the mutants and rapid loss of regeneration after photobleaching. These results define in GPCRs a canonical signal transduction mechanism where ligand binding induces conformational changes propagated through adjacent trigger, linking core, and coupling regions.

1 April 1995 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MVMartine Vaxillaire
Martine Vaxillaire
VBValérie Boccio
Valérie Boccio
APAnne Philippi
Anne Philippi
CVCorinne Vigouroux
Corinne Vigouroux
JTJoe Terwilliger
Joe Terwilliger
PFPhilippe Froguel
Philippe Froguel

1 March 1995 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JHJ. Hager
J. Hager
LHL. Hansen
L. Hansen
CVC. Vaisse
C. Vaisse
NVN. Vionnet
N. Vionnet
APA. Philippi
A. Philippi
PFP. Froguel
P. Froguel

1 September 1997 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
HZHabib Zouali
Habib Zouali
EHEl Habib Hani
El Habib Hani
APAnne Philippi
Anne Philippi
NVNathalie Vionnet
Nathalie Vionnet
JBJacques S. Beckmann
Jacques S. Beckmann
PFPhilippe Froguel
Philippe Froguel
Several candidate genes for non-insulin-dependent diabetes mellitus (NIDDM) map on chromosome 20, including the phosphoenolpyruvate carboxykinase gene (PCK1) and one of the maturity onset diabetes of the young genes (MODY1). Thus, we have investigated the entire long arm of chromosome 20. Linkage analyses were conducted in a total sample of 148 NIDDM families (301 NIDDM sib pairs) and in a subset of 42 early onset NIDDM families, where genetic components are likely to play a more important role (55 NIDDM sib pairs diagnosed at or before 45 years of age), using 10 highly polymorphic markers with an average map density of 7.5 cM. Using affected sib pair methods (two-point linkage and multipoint linkage analyses), significant results were obtained with the 20q13 region, in the vicinity of the PCK1 locus, only in the subset of 55 early onset NIDDM sib pairs (multipoint MLS = 2.74, P = 0.0004; MLS = 2.34, P = 0.0009 when using a conservative weighting procedure). Moreover, another region spanning the ribophorin II (RPNII), phospholipase C (PLC1) and adenosine deaminase (ADA) loci suggested linkage with NIDDM (multipoint MLS of 1.81 in all NIDDM sib pairs, P= 0.003; MLS = 1.31, P = 0.012 when using a conservative weighting procedure). Whereas our study suggests the location of a susceptibility locus for early onset NIDDM in the PCK1 gene region, further investigation in larger data sets is required to confirm these results and assess the role of other regions on chromosome 20q in human NIDDM.